03/29/2026
Christine Bestvina, MD, UChicago Medicine, discusses the trials she’s anticipating readouts for in 2026. The discussion highlights a first-of-its-kind randomized trial comparing divarasib vs adagrasib and sotorasib for patients with KRAS G12C mutations in the second and third line. The conversatio...